Last $0.07 USD
Change Today -0.0166 / -19.30%
Volume 7.3M
DNDNQ On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John H. Johnson

Former Chief Executive Officer, Dendreon Corp.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 3 different organizations across 8 different industries.

See Board Relationships
56--
As of Fiscal Year 2013

Background*

Mr. John H. Johnson is a Founder of The Atlantic Foundation. Mr. Johnson served as the President of Dendreon Corp. from February 2012 to July 2014 and served as its Chief Executive Officer from February 2012 to August 15, 2014. Mr. Johnson served as the Chief Executive Officer of Savient Pharmaceuticals, Inc. from January 31, 2011 to February 1, 2012 and served as its President until February 1, 2012. He served as the President and Head of Lilly Oncology (Oncology Business ...

Read Full Background

Corporate Headquarters*

1301 2nd Avenue
Seattle, Washington 98101

United States

Phone: 206-256-4545
Fax: 206-256-0571

Board Members Memberships*

Former Director
Former Chief Executive Officer, President and Director
Former Chairman of the Board
Former Director
2007-2008
Former President of Global Oncology Business Unit - Eli Lilly and Company
2009-Present
Director, Member of Nominating & Governance Committee and Member of Audit Committee
2010-N/A
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2011-2014
Former Chief Executive Officer
2013-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Director and Chairman of Compensation Committee

Education*

BS
East Stroudsburg University
BS
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DNDNQ:US $0.07 USD -0.0166

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DENDREON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.